Alexandria for Pharmaceuticals’ profits up 7.7% YoY in FY2022/23
Updated 9/6/2023 9:18:00 AM
Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries posted a 7.67% year-on-year (YoY) increase in its net profit after tax in the fiscal year (FY) 2022/2023, according to the company’s unaudited financial statement on September 6th.
Net profits after tax recorded EGP 126.427 million last FY, up from EGP 117.421 million in the prior FY.
Meanwhile, the firm garnered EGP 1.486 billion in revenues during FY 2022/2021, a 34.9% annual surge from EGP 1.101 billion.
Alexandria Pharmaceuticals, an affiliated company of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary and nutritional food products, as well as medical appliances such as adhesive plasters, dental cartridges, medicated adhesive tapes, sterile gauze dressing, and surgical gloves.
Related News
